Awards & Grants

From now on, an improved research infrastructure for pandemic management and prevention will be available in the Greater Munich area: on the 29th of March 2023 a new biosafety level 3 laboratory was introduced at Helmholtz Munich. The project could…

The EU-funded ISLET project brings together leading experts in the field of stem cell research to discover a new advanced cell therapy in type 1 diabetes. The aim is to free patients from the daily use of an insulin pump by replacing the damaged…

The German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) awarded Fabian Theis the Gottfried Wilhelm Leibniz Prize – the most prestigious research award in Germany. Fabian Theis is Head of the Computational Health Center at Helmholtz…

Munich scientists from the fields of proteomics, informatics, and medicine are working together on a large-scale project to investigate the causes of diseases of the central nervous system, how they can be diagnosed, and how treatment can be…

The X-ray of the human brain closeup image

Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the radiopharmaceutical company ITM Isotope Technologies…

Amyotrophic Lateral Sclerosis (ALS) is a non-curable degenerative disease of the motor nervous system. The cause of the disease is largely unknown: In addition to genetic factors, viruses are also suspected to be involved in the development of the…

Awards & Grants

News

Better Prepared in Future: Research Infrastructure for Pandemic Management and Prevention Expanded

EU-Project ISLET: Helmholtz Munich takes over coordination

Fabian Theis wins Leibniz Prize 2023

CLINSPECT-M: Clinical Mass Spectrometry Center for Molecular Brain Research goes into extension

Targeting Brain Tumors: New Drug Candidate in Clinical Trial

On the trail of the virus: New Grant supports INET project for preventing ALS